0001884272-21-000001.txt : 20210927 0001884272-21-000001.hdr.sgml : 20210927 20210927125750 ACCESSION NUMBER: 0001884272-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210927 DATE AS OF CHANGE: 20210927 EFFECTIVENESS DATE: 20210927 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Mined Therapeutics, Inc. CENTRAL INDEX KEY: 0001884272 IRS NUMBER: 863595671 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-414680 FILM NUMBER: 211280284 BUSINESS ADDRESS: STREET 1: 245 FIRST STREET STREET 2: 18TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-595-5769 MAIL ADDRESS: STREET 1: 245 FIRST STREET STREET 2: 18TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 D 1 primary_doc.xml X0708 D LIVE 0001884272 Mined Therapeutics, Inc. 245 FIRST STREET 18TH FLOOR CAMBRIDGE MA MASSACHUSETTS 02142 617-595-5769 MASSACHUSETTS None None Corporation true 2021 ANDREW SANDFORD 245 First Street 18th Floor Cambridge MA MASSACHUSETTS 02421 Executive Officer Director ALEX KOGLIN 245 First Street 18th Floor Cambridge MA MASSACHUSETTS 02421 Director DAVID SELDIN 245 First Street 18th Floor Cambridge MA MASSACHUSETTS 02421 Director THOMAS NICKOLOFF 245 First Street 18th Floor Cambridge MA MASSACHUSETTS 02421 Director Biotechnology Decline to Disclose 06b false 2021-09-15 false true false 0 6999998 6999998 0 false 18 0 0 0 false Mined Therapeutics, Inc. Andrew Sandford Andrew Sandford Chief Executive Officer 2021-09-27